99% Savings - Buy Just @1 Rs X
Ampirok 1000/500 Injection is a commercial drug that is prescribed in the form of Injection. Secondary and off-label uses of Ampirok 1000/500 Injection have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Ampirok 1000/500 Injection. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
While these are the most often observed Ampirok 1000/500 Injection side effects, there are can be others also. These have been listed below. Such side effects of Ampirok 1000/500 Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Ampirok 1000/500 Injection's effect during pregnancy is Safe and Safe while nursing. In addition, Ampirok 1000/500 Injection's effects on the liver, heart and kidney are discussed below in the Ampirok 1000/500 Injection related warnings section.
Ampirok 1000/500 Injection is contraindicated in people with pre-existing medical conditions like Kidney Disease, Kidney Disease, Jaundice as it can result in adverse effects. The section on Ampirok 1000/500 Injection contraindications lists all such conditions.
Additionally, Ampirok 1000/500 Injection may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Ampirok 1000/500 Injection is considered not safe while driving, and is not addictive.
Ampirok 1000/500 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Ampirok 1000/500 Injection is used -
Moderate
Mild
Is the use of Ampirok 1000/500 Injection safe for pregnant women?
Pregnant women can take Ampirok safely.
Is the use of Ampirok 1000/500 Injection safe during breastfeeding?
Breastfeeding women can safely use Ampirok.
What is the effect of Ampirok 1000/500 Injection on the Kidneys?
Ampirok may have mild side effects on the kidneys.
What is the effect of Ampirok 1000/500 Injection on the Liver?
Using Ampirok does not have any harmful effects on the liver.
What is the effect of Ampirok 1000/500 Injection on the Heart?
You can take Ampirok without any fear of damage to the heart.
If you are suffering from any of the following diseases, you should not take Ampirok 1000/500 Injection unless your doctor advises you to do so -
Is this Ampirok 1000/500 Injection habit forming or addictive?
No, you will not get addicted to Ampirok 1000/500 Injection.
Interaction between Food and Ampirok 1000/500 Injection
Ampirok 1000/500 Injection may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Ampirok 1000/500 Injection
It is difficult to say anything about the effect of Ampirok 1000/500 Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ampicillin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 722-723
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 158-160
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162